Thoma Bravo is negotiating the terms of a potential deal with Verint (VRNT), which is working with an adviser, Bloomberg ...

ServiceNow excels as a B2B software provider and has steadily grown revenues over the past decade. Find out why NOW stock is ...

Invesco Mortgage Capital is facing challenges with capital allocation and shareholder value. See why we have downgraded IVR ...

Elon Musk oversees Tesla's US & Europe sales after exec departure, reshaping leadership amid sales slumps and declining ...

British American Tobacco remains attractively valued with a low P/E ratio and a robust dividend yield, providing a margin of ...

XEQT is a low-cost, all-in-one global equity ETF offering strong diversification, 12.08% annual returns, and a 2.05% dividend ...

The Australian manufacturing sector is contracting further, as evidenced by the Ai Group Industry Index falling to ...

Yext's bottom line is improving, but organic growth remains challenged. Click here to see why YEXT stock is a Hold.

Kura Oncology's ziftomenib shows promise in AML treatment, with FDA Priority Review ahead. Read here for an analysis of KURA ...

Overweight position in the CMBS sector, particularly the AAA Agency subcomponent, was accretive to the NYLI Short Term Bond ...

Thrivent Mid Cap Value Fund underperformed its benchmark, Russell Midcap Value Index, during the quarter driven by negative ...

Meta's AI investments, open-source strategy, and Zuckerberg's bold vision position it as a leader against OpenAI & Google.